Ion Opticks Pty Ltd.. (10/25/24). "Press Release: Sciex and IonOpticks Announce Co-Marketing Agreement Between Aurora Series XS Range and the ZenoTOF Line". Melbourne.

	Organisation	Ion Opticks Pty Ltd. (IonOpticks)
	Organisation 2	AB Sciex (Danaher, Framingham, MA)
	Group	Danaher (Group)
	Product	HPLC (high performance liquid chromatography)
	Product 2	ZenoTOF 7600+ LC-MS/MS system
	Person	Sinden, Michael (Ion Opticks 202409)
	Person 2	VanZandt, Lulu (Danaher 201807 Brand, Public Relations + Social Media at Sciex)

IonOpticks, a leading global producer of high-performance chromatography solutions and SCIEX a global leader in life science analytical technologies, announce a collaboration to co-market the Aurora Series XS range with the ZenoTOF line, including the latest ZenoTOF 7600+ system.

The Aurora Series XS range has the unique design to optimise peptide and protein analysis on the ZenoTOF line, enabling researchers to unlock a new level of sensitivity. It is the leading commercial column in proteomics, with proprietary technology differentiated by two key technological advancements:

> A unique packed emitter design that enables maximum mobile phase velocity with no post-column dead volume.

> The nanoZero technology that provides user friendly ‘plug and play’ connections with true zero pre-column dead volume.

These features combine to maximise chromatographic efficiency and dramatically enhance proteomics performance.

The enhanced sensitivity demonstrated by the combination of the Aurora Series XS range and the ZenoTOF line allows for the identification and quantitation of proteins from complex samples with unprecedented accuracy and significantly expands the depth of proteome coverage. Furthermore, the high-sensitivity analysis facilitated by the Aurora Series XS columns on the ZenoTOF line enables stable and reproducible quantitation across multiple samples and presents a powerful approach for advancing proteomics research.

“We developed the Aurora Series to provide researchers with cutting-edge chromatographic tools that enhance their sample analysis capabilities. Collaborating with SCIEX will allow us to combine our strengths, integrating our XS range with their ZenoTOF line to deliver innovative solutions that expand the possibilities of proteomics research. Our joint mission is to advance human health, and we’re excited to work alongside SCIEX in bringing these solutions to both our existing and new customers, helping them achieve the highest performance with their systems,” said Dr. Jarrod Sandow, Chief Product Officer at IonOpticks.

Ihor Batruch, Technical Product Manager at SCIEX said of the collaboration, “It’s been a real pleasure working with IonOpticks on the development of these columns and to be able to use them and have them integrated well with our ZenoTOF systems. At this point, I would say these columns are the best on the market. They’ll allow you to explore more of the proteome with significant gains in performance, coverage and sensitivity.”

The Aurora Series range was developed to enhance chromatographic performance for LC-MS applications. Further information can be found at www.ionopticks.com

MEDIA CONTACTS

Michael Sinden
Chief Brand Officer
michael@ionopticks.com

Lulu VanZandt
Senior Manager, Brand, Public Relations and Social Media
lulu.vanzandt@sciex.com

About IonOpticks:

IonOpticks produces high-performance chromatography solutions for the global research community enhancing mass spectrometry (LC-MS) and high-end proteomics research. Their solutions enhance the sensitivity of mass spectrometry sample analysis, enabling scientists and clinicians to discover more from their samples. These advancements are valuable for a broad range of applications within the field of biological and medical research including drug discovery, phosphoproteomics and shotgun proteomics. https://ionopticks.com/

About SCIEX

SCIEX empowers our customers to solve the most impactful analytical challenges in quantitation and characterization. With groundbreaking innovation and outstanding reliability and support, SCIEX has been at the forefront of the field for over 50 years. ?Since the launch of the first-ever commercially successful triple quadrupole in 1981, we continue to develop technologies and solutions that influence life-changing research and outcomes. That’s why thousands of life science experts around the world choose SCIEX to get the answers they can trust. ?Advances in human wellness depend on the power of precise science.? For more information, visit sciex.com. ?

Record changed: 2024-11-25